Urban Fagerholm
Professor and pharmacokinetics
Role in PharmNovo: Consultant and pharmacokinetics advisor
Company: Prosilico AB
Resumé: Started Prosilico focuses on human and animal ADMET-predictions using new, unique algorithms and in-silico models. Their validated, context-based models (more than 50, including many exclusive) clearly outperform state-of-the-art in-vitro and animal in-vivo methods both regarding quality, range, speed and overview. Prosilicos’ services include advice, early decision-support, compound profiling, risk assessment, platform customization and in/out-licensing evaluation.
Member of:
